Telatinib Completed Phase 2 Trials for Gastric Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00952497A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer